Literature DB >> 9037611

Adsorption-induced antigenic changes and their significance in ELISA and immunological disorders.

J E Butler1, P Navarro, J Sun.   

Abstract

The functional properties of 125I-labeled antibodies and antigens adsorbed on polystyrene and silicone were compared to their counterparts immobilized by non-adsorptive methods. Less than 20% of polyclonal (pAb) and 1-2% of monoclonal (mAb) capture antibody equivalents remained functional after adsorption as a monolayer. Survivability circa doubled or was totally rescued, when the same antibodies were immobilized via a streptavidin bridge or by using a first stage polyclonal antiglobulin capture antibody, respectively. Similarly, the antigenicity of bovine IgGs for pAb and mAb anti-IgGs was highest when the IgGs were immobilized via a streptavidin bridge or when secondarily adsorbed to an albumin monolayer. IgGs in these configurations were significantly more antigenic than when directly adsorbed on polystyrene or a silicone elastomer. Similar activity was seen after adsorption on polystyrene or silicone. Interestingly, these IgGs were equally antigenic when denatured and subsequently adsorbed in 6M guanidine-HCl versus adsorption in PBS without prior denaturation. Although many of the above finding on antibodies and antigens could be explained by the greater accessibility of antigenic epitopes or antibody binding sites when molecules are immobilized by some type of underlying molecular layer, we also show that certain mAb and pAbs preferentially recognized allotopes on IgG2a when IgG2a was adsorbed. Furthermore, such antigenicity was highest when IgG2a was adsorbed at low, sub-monolayer concentrations. Finally, we show that differences in antigenicity need not be related to the method of immobilization, but can also result from differences in the microenvironment of the epitope. This was demonstrated using a filamentous phage clone specific for fluorescein (FLU). This clone recognizes the fluorescein hapten differently depending on the carrier protein used and the method of conjugation. Data presented in this report indicate that antibodies and antigens adsorbed on hydrophobic polymers undergo changes in their functional properties. Data suggest that both changes in conformation and the accessibility of antigen epitopes or antibody binding sites, most likely occur. Especially in the case of the latter, the functional concentration may be 1-2 orders of magnitude lower than the antibody protein concentration. These observations have implications for immunodiagnostics and emphasize the need to determine the specificity of an antibody in the assay in which it is employed and to make no assumptions about the behavior of solid-phase antigens and antibodies from their behavior in solution. Our studies are also relevant to the use of silicone medical prostheses. The antigenicity of IgGs adsorbed on silicone as a multilayer (secondary layer) is much higher than when directly adsorbed. Since such surfaces would be exposed to very high protein concentrations in vivo, multilayers not a monolayer, would be expected. Thus it would seem from these studies that host protein adsorbed on silicone would be expressed to the immune system at the surface of multilayers. This being the case, it seems unlikely that the adsorption of host protein in vivo would generate new epitopes against which the host's immune system could respond and subsequently initiate an autoimmune syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037611     DOI: 10.3109/08820139709048914

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  7 in total

1.  Specific binder for Lightning-Link® biotinylated proteins from an antibody phage library.

Authors:  Fortunato Ferrara; Leslie A Naranjo; Sara D'Angelo; Csaba Kiss; Andrew R M Bradbury
Journal:  J Immunol Methods       Date:  2013-07-11       Impact factor: 2.303

2.  Droplet-based valveless microfluidic system for phage-display screening against spheroids.

Authors:  Tsuyohi Sato; Akira Hamai; Tetsuya Kadonosono; Shinae Kizaka-Kondoh; Toru Omata
Journal:  Biomicrofluidics       Date:  2022-04-13       Impact factor: 3.258

3.  Using phage and yeast display to select hundreds of monoclonal antibodies: application to antigen 85, a tuberculosis biomarker.

Authors:  Fortunato Ferrara; Leslie A Naranjo; Sandeep Kumar; Tiziano Gaiotto; Harshini Mukundan; Basil Swanson; Andrew R M Bradbury
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

4.  An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells.

Authors:  Anita M Dreyer; Jeremy Beauchamp; Hugues Matile; Gerd Pluschke
Journal:  BMC Biotechnol       Date:  2010-12-15       Impact factor: 2.563

5.  Versatile and Easily Designable Polyester-Laser Toner Interfaces for Site-Oriented Adsorption of Antibodies.

Authors:  Marcin Drozd; Polina Ivanova; Katarzyna Tokarska; Kamil Żukowski; Aleksandra Kramarska; Adam Nowiński; Ewa Kobylska; Mariusz Pietrzak; Zbigniew Brzózka; Elżbieta Malinowska
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

Review 6.  Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.

Authors:  Mohamed A Alfaleh; Hashem O Alsaab; Ahmad Bakur Mahmoud; Almohanad A Alkayyal; Martina L Jones; Stephen M Mahler; Anwar M Hashem
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

7.  Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.

Authors:  Katrina M Pollock; Hannah M Cheeseman; Alexander J Szubert; Vincenzo Libri; Marta Boffito; David Owen; Henry Bern; Jessica O'Hara; Leon R McFarlane; Nana-Marie Lemm; Paul F McKay; Tommy Rampling; Yee Ting N Yim; Ana Milinkovic; Cherry Kingsley; Tom Cole; Susanne Fagerbrink; Marites Aban; Maniola Tanaka; Savviz Mehdipour; Alexander Robbins; William Budd; Saul N Faust; Hana Hassanin; Catherine A Cosgrove; Alan Winston; Sarah Fidler; David T Dunn; Sheena McCormack; Robin J Shattock
Journal:  EClinicalMedicine       Date:  2022-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.